The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 02, 2017

Filed:

Dec. 01, 2014
Applicant:

Stemnion, Inc., Pittsburgh, PA (US);

Inventors:

Larry R Brown, Newton, MA (US);

George L Sing, New York, NY (US);

Howard C Wessel, Kensington, PA (US);

Assignee:

STEMNION, INC., Pittsburgh, PA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 35/50 (2015.01); A61K 38/19 (2006.01); A61K 9/00 (2006.01); A61K 9/19 (2006.01);
U.S. Cl.
CPC ...
A61K 35/50 (2013.01); A61K 9/0043 (2013.01); A61K 9/0046 (2013.01); A61K 9/19 (2013.01); A61K 38/19 (2013.01);
Abstract

The invention is directed to methods for treating ocular contusion and blunt injury to the eye and for treating traumatic injury of the optic nerve. The invention is further directed to treating ocular contusion and blunt injury to the eye and for treating traumatic injury of the optic nerve by administering to a subject suffering from such conditions Amnion-derived Cellular Cytokine Solution (ACCS), including immediate-release, targeted-release, and sustained-release (SR) ACCS compositions (referred to herein as 'SR-ACCS' compositions) and/or Amnion-derived Multipotent Progenitor (AMP) cell compositions. Such administration includes intranasal administration of ACCS and/or AMP cells.


Find Patent Forward Citations

Loading…